Quick Answer
Mirum Pharmaceuticals, Inc. reported Net Income of -$23.36 million for fiscal year 2025.
Mirum Pharmaceuticals, Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$23.36M | +73.4% |
| 2024 | -$87.94M | +46.2% |
| 2023 | -$163.41M | -20.5% |
| 2022 | -$135.66M | -61.5% |
| 2021 | -$83.99M | +18.7% |
| 2020 | -$103.27M | -96.5% |
| 2019 | -$52.55M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $2.90M | +120.4% | +149.6% |
| June 30, 2025 | -$5.86M | +76.2% | +60.1% |
| March 31, 2025 | -$14.68M | +41.9% | -3.1% |
| September 30, 2024 | -$14.23M | +39.7% | +42.2% |
| June 30, 2024 | -$24.64M | +66.7% | +2.5% |
| March 31, 2024 | -$25.28M | +16.1% | -7.2% |
| September 30, 2023 | -$23.59M | +33.9% | +68.1% |
| June 30, 2023 | -$74.04M | -175.0% | -145.7% |
- Mirum Pharmaceuticals, Inc. showed an increase of +73.4% in Net Income compared to the prior fiscal year.
- Over the 2019–2025 period, Mirum Pharmaceuticals, Inc.’s net income has grown by 55.5% (from -$52.55 million to -$23.36 million).
- The most recent figure is from Mirum Pharmaceuticals, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 25, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: